The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?

OBJECTIVE: Lower urinary tract symptoms (LUTS), which are related to benign prostate hyperplasia (BPH), are the most commonly encountered diseases in urological practice. In our study, we compared responses to (doxazosin mesylate extended release tablets) treatment. MATERIAL AND METHODS: In our stud...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Turk J Urol
Päätekijät: Karaman, Muhammet İhsan, Sertkaya, Zülfü, Koca, Orhan, Akyüz, Mehmet, Güneş, Mustafa, Öztürk, Metin İshak
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Turkish Association of Urology 2014
Aiheet:
Andrology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4548635/
https://ncbi.nlm.nih.gov/pubmed/26328143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tud.2014.31384
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia